When a person is able to consistently stay on a course of HIV treatment that works effectively, their quality of life improves and their viral load becomes undetectable, meaning they cannot transmit the HIV virus to others.
According to health officials, Panama’s embrace of Treatment as Prevention® (TasP® ) since 2014 has resulted in quicker diagnosis, as well as accelerating the linkage of patients to antiretroviral therapy (ART) clinics. The country’s HIV diagnoses curve has stabilized in recent years and officials expect it will decrease in the coming years. “We have achieved
Today, Panama cites TasP success in reducing HIV morbidity and mortality Read More »
New research from BC Centre for Excellence in HIV/AIDS (BC-CfE), Simon Fraser University (SFU) and Hawassa University in Ethiopia, found high rates HIV of drug resistance in Ethiopian children failing their first-line HIV treatment.
Scientists in Vancouver have developed a new screening tool that reveals the genetic signature of an individual’s hepatitis C virus so that doctors can customize their treatment. The tool, funded by Genome B.C. and devised by researchers at the B.C. Centre for Excellence in HIV/AIDS, could save money and lives, said Anita Howe, scientific lead
B.C. developed hepatitis C screening test personalizes treatment for patients Read More »
For 20 years, I’ve been advocating for people living with hepatitis C. I was diagnosed with hep C (formerly known as non-A, non-B hepatitis) in the early days of George H.W. Bush’s presidency. Clinton was president during my first treatment; George W. Bush resided during my second treatment. Obama held the office when I was
Hepatitis C and President Trump Read More »
One of the best ways to prevent the spread of HIV is to treat those at high risk with a daily prophylactic pill. Unfortunately, this week Stanford University health researchers concluded that it’s simply too expensive to pre-treat even a fraction of people at increased risk for HIV. But what if healthcare providers could track
Big Data Tamps Down HIV Outbreaks Read More »
The BC-CfE Research Laboratory advances our understanding of HIV and how it can best be treated. The cutting-edge facility, housed at St. Paul’s Hospital, acts as hub for genome research, receiving blood samples from across BC, Canada (not including Quebec) and countries around the world.
BC-CfE’s Lab Research: Cutting-Edge Advances in HIV/AIDS Read More »
The BC-CfE laboratory program took home the award for science, research and technology at the bi-annual AccolAIDS awards held on April 29, 2012 at the Vancouver Convention Centre. The gala honours the extraordinary achievements and dedication of organizations, businesses, groups and individuals responding to the AIDS epidemic in British Columbia, and the thousands of people
BC-CfE laboratory program wins science, research and technology award Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
